New WHO prequalification charges could scare off generics companies
This article was originally published in Scrip
Executive Summary
New application fees of up to $8,000 could discourage generics manufacturers from submitting their products for prequalification by the World Health Organization, non-governmental organizations have warned. The WHO decided to introduce fees amid concerns over the viability of its current funding model.